Literature DB >> 23110027

The Histologic Cut-off Point for Adjacent and Remote Non-neoplastic Liver Parenchyma of Hepatocellular Carcinoma in Chronic Hepatitis B Patients.

Hae Yoen Jung1, Soo Hee Kim, Jin Jing, Jae Moon Gwak, Chul Ju Han, Ja-June Jang, Kyoung-Bun Lee.   

Abstract

BACKGROUND: The molecular profile of peritumoral non-neoplastic liver parenchyma (PNLP) has recently been suggested as predictive factor of early and late recurrence of hepatocellular carcinoma (HCC). However, there is no definite cut-off point for tumor-free PNLP in terms of either histological or molecular changes. Therefore, our aim is to determine the numerical cut-off point for separating adjacent PNLP and remote PNLP in histopathologic perspective.
METHODS: Peritumoral tissues from 20 resected HCC patients were sampled from 0 to 40 mm distance from the tumor border (divided into 5-mm columns). Histopathologic parameters such as necroinflammatory activity, fibrosis, bile ductular reaction, hepatic venulitis, peliosis, and steatosis were compared between each column.
RESULTS: The morphologic changes just adjacent to the tumor were notably severe and faded with distance. The parenchyma within 10 mm of the tumor showed significantly severe inflammation, fibrosis, peliosis and hepatic venulitis compared with those from farther areas. The histopathologic changes of the parenchyma became stable beyond 20 mm.
CONCLUSIONS: Results of this study revealed that the parenchyma within 10 mm distance from the tumor, or adjacent PNLP, has histopathologic changes that are directly affected by the tumor, and the parenchyma beyond 20 mm as the remote PNLP without tumor effect.

Entities:  

Keywords:  Carcinoma, hepatocellular; Hepatitis B, chronic; Nonneoplastic liver parenchyma

Year:  2012        PMID: 23110027      PMCID: PMC3479819          DOI: 10.4132/KoreanJPathol.2012.46.4.349

Source DB:  PubMed          Journal:  Korean J Pathol        ISSN: 1738-1843


  23 in total

1.  Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.

Authors:  R T Poon; S T Fan; I O Ng; C M Lo; C L Liu; J Wong
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

2.  Recurrence of hepatocellular carcinoma after liver transplantation: recurrence characteristics and risk factors.

Authors:  Chuan Li; Tian-Fu Wen; Zhi-Xue Liao; Lv-Nan Yan; Bo Li; Yong Zeng; Wen-Tiao Wang; Ming-Qing Xu; Jia-Ying Yang; Yong-Gang Wei
Journal:  Hepatogastroenterology       Date:  2010 May-Jun

3.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

4.  Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.

Authors:  Min-Jie Ju; Shuang-Jian Qiu; Jia Fan; Yong-Sheng Xiao; Qiang Gao; Jian Zhou; Yi-Wei Li; Zhao-You Tang
Journal:  Am J Clin Pathol       Date:  2009-04       Impact factor: 2.493

5.  Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.

Authors:  Masahiro Okamoto; Tohru Utsunomiya; Shigeki Wakiyama; Masaji Hashimoto; Kengo Fukuzawa; Takahiro Ezaki; Taizo Hanai; Hiroshi Inoue; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

6.  Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.

Authors:  J Belghiti; Y Panis; O Farges; J P Benhamou; F Fekete
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

7.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

8.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 9.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Authors:  R Tung-Ping Poon; S T Fan; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

10.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

View more
  4 in total

1.  Prognostic value of non-invasive fibrosis indices post-curative resection in hepatitis-B-associated hepatocellular carcinoma patients.

Authors:  Ting-Ting Zhang; Si-Si Ye; Jun Liang; Li Bai
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-29

2.  Renal histologic parameters influencing postoperative renal function in renal cell carcinoma patients.

Authors:  Myoung Ju Koh; Beom Jin Lim; Kyu Hun Choi; Yon Hee Kim; Hyeon Joo Jeong
Journal:  Korean J Pathol       Date:  2013-12-24

3.  Evaluation of Peritumoral Fibrosis in Metastatic Colorectal Adenocarcinoma to the Liver Using Digital Image Analysis.

Authors:  Kevin M Waters; Tricia R Cottrell; Sepideh Besharati; Qingfeng Zhu; Robert A Anders
Journal:  Am J Clin Pathol       Date:  2019-01-07       Impact factor: 2.493

4.  Fibrosis-4 Model Influences Results of Patients with Hepatocellular Carcinoma Undergoing Hepatectomy.

Authors:  Haiqing Wang; Aixiang Liu; Wentao Bo; Xielin Feng; Yong Hu; Lang Tian; Hui Zhang; Xiaoli Tang; Lixia Zhang
Journal:  Biomed Res Int       Date:  2018-07-02       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.